Clinical significance of circulating tumor cells in the response to trastuzumab for HER2-negative metastatic gastric cancer
出版年份 2021 全文链接
标题
Clinical significance of circulating tumor cells in the response to trastuzumab for HER2-negative metastatic gastric cancer
作者
关键词
-
出版物
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-02-28
DOI
10.1007/s00280-021-04251-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparison of HER2 Status Before and After Trastuzumab-based Chemotherapy in Patients With Advanced Gastric Cancer
- (2020) TAKASHI KIJIMA et al. ANTICANCER RESEARCH
- Evolutionary expression of HER2 conferred by chromosome aneuploidy on circulating gastric cancer cells contributes to developing targeted and chemotherapeutic resistance
- (2018) Yilin Li et al. CLINICAL CANCER RESEARCH
- HER2 copy number of circulating tumour DNA functions as a biomarker to predict and monitor trastuzumab efficacy in advanced gastric cancer
- (2018) Haixing Wang et al. EUROPEAN JOURNAL OF CANCER
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Re-evaluation of HER2 status in patients with HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab (KSCC1604)
- (2018) Hiroshi Saeki et al. EUROPEAN JOURNAL OF CANCER
- Clinicopathological factors associated with HER2-positive gastric cancer
- (2017) Hong-Bo Wang et al. MEDICINE
- Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients
- (2017) Yuji Mishima et al. Targeted Oncology
- The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature
- (2017) Yu-ying Lei et al. World Journal of Surgical Oncology
- The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial
- (2017) B. A. S. Jaeger et al. PLoS One
- Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients
- (2016) Shaohua Zhang et al. BMC CANCER
- A rising trend in the incidence of advanced gastric cancer in young Hispanic men
- (2016) Shaila J. Merchant et al. Gastric Cancer
- Japanese gastric cancer treatment guidelines 2014 (ver. 4)
- (2016) Gastric Cancer
- Clinical Significance of Circulating Tumor Cells in Peripheral Blood of Patients with Esophageal Squamous Cell Carcinoma
- (2015) Daisuke Matsushita et al. ANNALS OF SURGICAL ONCOLOGY
- Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer
- (2015) Naoyuki Tominaga et al. Gastric Cancer
- Clinical significance of circulating tumor cells in peripheral blood from patients with gastric cancer
- (2013) Yoshikazu Uenosono et al. CANCER
- Clinical significance of intratumoral HER2 heterogeneity in gastric cancer
- (2012) Hee Eun Lee et al. EUROPEAN JOURNAL OF CANCER
- HER2-Positive Circulating Tumor Cells in Breast Cancer
- (2011) Michail Ignatiadis et al. PLoS One
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer
- (2009) M. A. Leversha et al. CLINICAL CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More